Educational Breast Cancer Event Focuses on Individual Disease Types

CINCINNATI—Sort of like snowflakes, no two breast cancers are exactly alike.

To educate on how breast cancers differ at the genetic level and how these differences lead to personalized treatment, as well as discussions on the latest in breast cancer research and explanations on how risk and recurrence can be minimized, the University of Cincinnati (UC) Cancer Institute’s Breast Cancer Center is hosting a free educational event for survivors, their families and the community.

The "We See Individual Breast Cancers: You See Personalized Care” breast cancer conference, being held from 9 a.m. to 3 p.m. Saturday Nov. 4, at the Kingsgate Marriott Conference Center, 151 Goodman Drive, is free and open to the public. The event will involve presentations from experts within the institute at UC, the community and beyond.

Tina Hieken, MD, associate professor of surgery at Mayo Clinic, will be the featured speaker for the day and will be presenting on the breast microbiome—exploring the impact of local bacteria and other microorganisms on breast health. 

Other talks will touch on "tumor mapping,” genetic profiling, targeted therapies and why certain genes make a person more susceptible to cancer. 

"This year, we’re taking a close look into the genes and pathways that make each cancer different,” says Elyse Lower, MD, director of the center, professor in the Division of Hematology Oncology at the UC College of Medicine and a UC Health oncologist. "This annual event allows us to educate attendees about new advances in personalized medicine and what our experts at the UC Cancer Institute are doing to fight this disease. We’re excited to host the conference again this year to empower patients and members of the community and to showcase our strengths locally.”

>> Register online 

Related Stories

2

At least two weather patterns increase headaches, UC study suggests

June 4, 2026

University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.